Current Controversy and Developments Regarding the Cytoreductive Prostatectomy for Oligometastatic Prostate Cancer
Oligometastatic prostate cancer is a term that is most often used to refer to limited sites of disseminated tumor growth following primary radical prostatectomy (RP) or radiotherapy (RT), while de novo oligometastatic is a term that is used to refer to prostate tumors that have disseminated to limit...
Main Authors: | Yuan Tian MS, Yifeng Mao MS, Zhizhong Tang MD, PhD, Mingqiu Hu MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338231216011 |
Similar Items
-
A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease
by: Andrey Morozov, et al.
Published: (2024-04-01) -
Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
by: Michael Chaloupka, et al.
Published: (2021-11-01) -
The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer
by: D. Cannoletta, et al.
Published: (2020-10-01) -
Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
by: Doo Yong Chung, et al.
Published: (2023-05-01) -
Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis
by: Yifeng Mao, et al.
Published: (2022-08-01)